A study led by OUCRU Indonesia and the Faculty of Medicine Universitas Indonesia (FMUI) found that 9 out of 10 hospitals, in a sample of 575 across 34 provinces of Indonesia, had a formal Antimicrobial Stewardship Programme. But only half of those had reached a development level where they could run a robust, functional stewardship programme.
The Pandemic Sciences Institute has signed a Memorandum of Understanding with Universiti Malaysia Sabah (UMS), to advance a shared understanding of the risks of emerging viruses in regions rich in biodiversity.
Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.
Last month the final two Oxford-GSK Institute of Molecular and Computational Medicine (IMCM) Fellows were welcomed to NDM\u2019s Centre for Human Genetics. Dr Martina Hallegger and Dr Charmaine Lang join Dr Steph Fowler to build capacity in neurodegenerative disease research at the Centre.
In an exciting collaboration between academia and industry, researchers at NDM\u2019s Centre for Medicines Discovery and Boehringer Ingelheim have discovered the reaction mechanism for human ceramide synthase (CerS), which could help to form CerS-inhibiting products in the future.
Increased genomic surveillance capacity during the pandemic allowed researchers to get a deeper insight into the global distribution patterns of seasonal flu and other respiratory viruses.
Using antibody data and mathematical modelling, a new study from researchers at the Pandemic Sciences Institute estimates annual patterns of influenza infection and protection over the past fifty years.
Professor David Aanensen, Principal Investigator at the Pandemic Sciences Institute and Big Data Institute, has been honoured with the 2025 Translational Microbiology Prize in recognition for his work in the areas of translational microbiology and genomic epidemiology.
Researchers at NDM\u2019s Oxford University Clinical Research Unit (OUCRU) have identified gene activity signatures in the blood of patients with a life-threatening form of tuberculosis.
Prof Andrew Brent has been granted the title of Visiting Professor of Infectious Diseases and General Medicine, in recognition of his successful collaboration with the University of Oxford.
Dr Chewapreecha, a Wellcome International Intermediate Fellow and computational biologist at NDM's Mahidol-Oxford Tropical Medicine Research Unit, has been announced as the Individual Winner at this year\u2019s Inspiring Women in Science Awards hosted by Nature and The Est\u00e9e Lauder Companies. She was honoured at a ceremony in London on 31 October.
The Royal Society for Tropical Medicine and Hygiene recently awarded MORU\u2019s Professor Lorenz von Seidlein (centre) the Donald Mackay Medal in London for outstanding work in tropical health.
Scientists in the Nuffield Department of Medicine and the Icahn School of Medicine at Mount Sinai have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade existing vaccines and therapies.
To mark liver cancer awareness month, we are excited to announce the launch of the Oxford LIVer cancer centre of Excellence (OLivE) to improve outcomes for liver cancer patients.
In a world first, researchers at the Kennedy Institute of Rheumatology and the Nuffield Department of Medicine have mapped the cellular dynamics following treatment with the most commonly used advanced therapy in autoimmune diseases. They have discovered why some patients benefit from this therapy while others do not, potentially paving the way for new therapies.
A new study from researchers in the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC), hosted at NDM\u2019s Pandemic Sciences Institute, reveals the key Long COVID characteristics affecting populations worldwide, including fatigue, shortness of breath and having trouble thinking clearly.
The Global Health Network, hosted by NDM, proudly announced the official launch of its Middle East North Africa (MENA) Regional Hub, an initiative set to revolutionise health research, education, and practice across the region. The launch event was held at the Canadian University Dubai on the 21st October 2024, and brought together leading experts, policymakers, and academic institutions to chart a path toward a healthier and more resilient future for the MENA region.
On Thursday, Nigeria announced the regulatory approval and launch of the new R21/Matrix-M\u2122 malaria vaccine that will be freely administered to recipients. This marks a significant milestone in the country\u2019s fight against the deadly disease.
A new study published in Nature Communications has identified a new potential transmission route for H5 highly pathogenic avian influenza viruses (HPAI). Understanding actual \u201cbird flu\u201d rates in humans will help prevent further spillover and a potential new pandemic.
In a new study, published in NPJ Vaccines, researchers from the Pandemic Sciences Institute and The Pirbright Institute have generated new evidence supporting the development of a universal influenza vaccine.
![\"Antibiotics\"](\"https://www.ndm.ox.ac.uk/news/indonesia-faces-gaps-in-hospital-antibiotic-programmes-amid-antimicrobial-resistance-issue/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n